These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 26259630

  • 1. Next-generation antimicrobials: from chemical biology to first-in-class drugs.
    Ang ML, Murima P, Pethe K.
    Arch Pharm Res; 2015 Sep; 38(9):1702-17. PubMed ID: 26259630
    [Abstract] [Full Text] [Related]

  • 2. Development of Mycobacterium tuberculosis whole cell screening hits as potential antituberculosis agents.
    Cooper CB.
    J Med Chem; 2013 Oct 24; 56(20):7755-60. PubMed ID: 23927683
    [Abstract] [Full Text] [Related]

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 24; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 4. Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening.
    Manjunatha UH, Smith PW.
    Bioorg Med Chem; 2015 Aug 15; 23(16):5087-97. PubMed ID: 25577708
    [Abstract] [Full Text] [Related]

  • 5. In silico analyses for the discovery of tuberculosis drug targets.
    Chung BK, Dick T, Lee DY.
    J Antimicrob Chemother; 2013 Dec 15; 68(12):2701-9. PubMed ID: 23838951
    [Abstract] [Full Text] [Related]

  • 6. Phenotypic screening as a strategic component of drug discovery programs targeting novel antiparasitic and antimycobacterial agents: an editorial.
    Butera JA.
    J Med Chem; 2013 Oct 24; 56(20):7715-8. PubMed ID: 23927625
    [Abstract] [Full Text] [Related]

  • 7. Application of chemical biology in target identification and drug discovery.
    Zhu Y, Xiao T, Lei S, Zhou F, Wang MW.
    Arch Pharm Res; 2015 Sep 24; 38(9):1642-50. PubMed ID: 26242900
    [Abstract] [Full Text] [Related]

  • 8. IspC as target for antiinfective drug discovery: synthesis, enantiomeric separation, and structural biology of fosmidomycin thia isosters.
    Kunfermann A, Lienau C, Illarionov B, Held J, Gräwert T, Behrendt CT, Werner P, Hähn S, Eisenreich W, Riederer U, Mordmüller B, Bacher A, Fischer M, Groll M, Kurz T.
    J Med Chem; 2013 Oct 24; 56(20):8151-62. PubMed ID: 24032981
    [Abstract] [Full Text] [Related]

  • 9. Structure based drug discovery for designing leads for the non-toxic metabolic targets in multi drug resistant Mycobacterium tuberculosis.
    Kaur D, Mathew S, Nair CGS, Begum A, Jainanarayan AK, Sharma M, Brahmachari SK.
    J Transl Med; 2017 Dec 21; 15(1):261. PubMed ID: 29268770
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Considerations of the chemical biology of microbial natural products provide an effective drug discovery strategy.
    Choi H, Oh DC.
    Arch Pharm Res; 2015 Sep 21; 38(9):1591-605. PubMed ID: 26231248
    [Abstract] [Full Text] [Related]

  • 13. Diarylquinolines, synthesis pathways and quantitative structure--activity relationship studies leading to the discovery of TMC207.
    Guillemont J, Meyer C, Poncelet A, Bourdrez X, Andries K.
    Future Med Chem; 2011 Sep 21; 3(11):1345-60. PubMed ID: 21879841
    [Abstract] [Full Text] [Related]

  • 14. Unconventional screening approaches for antibiotic discovery.
    Farha MA, Brown ED.
    Ann N Y Acad Sci; 2015 Sep 21; 1354():54-66. PubMed ID: 26100135
    [Abstract] [Full Text] [Related]

  • 15. Role of Chemical Biology in Tuberculosis Drug Discovery and Diagnosis.
    Kolbe K, Veleti SK, Johnson EE, Cho YW, Oh S, Barry CE.
    ACS Infect Dis; 2018 Apr 13; 4(4):458-466. PubMed ID: 29364647
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combinatorial lead discovery and optimization of antimicrobial oxazolidinones.
    Gordeev MF.
    Curr Opin Drug Discov Devel; 2001 Jul 13; 4(4):450-61. PubMed ID: 11727310
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The future for early-stage tuberculosis drug discovery.
    Zuniga ES, Early J, Parish T.
    Future Microbiol; 2015 Jul 13; 10(2):217-29. PubMed ID: 25689534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.